Mary T Szela - Net Worth and Insider Trading
Mary T Szela Net Worth
The estimated net worth of Mary T Szela is at least $12 Million dollars as of 2024-05-25. Mary T Szela is the Senior Vice President of Abbott Laboratories and owns about 119,422 shares of Abbott Laboratories (ABT) stock worth over $12 Million. Mary T Szela is also the Director of Coherus BioSciences Inc and owns about 0 shares of Coherus BioSciences Inc (CHRS) stock worth over $0. Details can be seen in Mary T Szela's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mary T Szela has not made any transactions after 2020-06-22 and currently still holds the listed stock(s).
Transaction Summary of Mary T Szela
Mary T Szela Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mary T Szela owns 10 companies in total, including Kura Oncology Inc (KURA) , Coherus BioSciences Inc (CHRS) , and Alimera Sciences Inc (ALIM) among others .
Click here to see the complete history of Mary T Szela’s form 4 insider trades.
Insider Ownership Summary of Mary T Szela
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
KURA | Kura Oncology Inc | 2018-11-06 | director |
CHRS | Coherus BioSciences Inc | 2020-06-22 | director |
ALIM | Alimera Sciences Inc | 2018-06-19 | director |
2017-05-09 | director & Chief Executive Officer | ||
2016-11-29 | director & Chief Executive Officer | ||
2011-12-14 | Senior Vice President | ||
2021-03-11 | director | ||
2021-07-29 | director | ||
2023-08-10 | director & CEO and President | ||
2023-08-10 | director & CEO and President |
Mary T Szela Latest Holdings Summary
Mary T Szela currently owns a total of 2 stocks. Among these stocks, Mary T Szela owns 119,422 shares of Abbott Laboratories (ABT) as of December 14, 2011, with a value of $12 Million and a weighting of 100%. Mary T Szela also owns 0 shares of Coherus BioSciences Inc (CHRS) as of June 22, 2020, with a value of $0 and a weighting of 0%.
Latest Holdings of Mary T Szela
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ABT | Abbott Laboratories | 2011-12-14 | 119,422 | 103.95 | 12,413,917 |
CHRS | Coherus BioSciences Inc | 2020-06-22 | 0 | 1.91 | 0 |
Holding Weightings of Mary T Szela
Mary T Szela Form 4 Trading Tracker
According to the SEC Form 4 filings, Mary T Szela has made a total of 0 transactions in Abbott Laboratories (ABT) over the past 5 years. The most-recent trade in Abbott Laboratories is the sale of 53,201 shares on December 14, 2011, which brought Mary T Szela around $3 Million.
According to the SEC Form 4 filings, Mary T Szela has made a total of 1 transactions in Coherus BioSciences Inc (CHRS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Coherus BioSciences Inc is the sale of 54,997 shares on June 22, 2020, which brought Mary T Szela around $966,847.
Insider Trading History of Mary T Szela
- 1
Mary T Szela Trading Performance
Mary T Szela Ownership Network
Ownership Network List of Mary T Szela
Ownership Network Relation of Mary T Szela
Mary T Szela Owned Company Details
What does Kura Oncology Inc do?
Who are the key executives at Kura Oncology Inc?
Mary T Szela is the director of Kura Oncology Inc. Other key executives at Kura Oncology Inc include Chief Legal Officer Teresa Brophy Bair , Chief Medical Officer Stephen Dale , and SVP & Finance & Accounting Thomas James Doyle .
Kura Oncology Inc (KURA) Insider Trades Summary
Over the past 18 months, Mary T Szela made no insider transaction in Kura Oncology Inc (KURA). Other recent insider transactions involving Kura Oncology Inc (KURA) include a net sale of 21,208 shares made by Stephen Dale , a net sale of 4,668 shares made by Teresa Brophy Bair , and a net sale of 3,866 shares made by Thomas James Doyle .
In summary, during the past 3 months, insiders sold 2,615 shares of Kura Oncology Inc (KURA) in total and bought 0 shares, with a net sale of 2,615 shares. During the past 18 months, 126,017 shares of Kura Oncology Inc (KURA) were sold and 50,000 shares were bought by its insiders, resulting in a net sale of 76,017 shares.
Kura Oncology Inc (KURA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kura Oncology Inc Insider Transactions
Mary T Szela Mailing Address
Above is the net worth, insider trading, and ownership report for Mary T Szela. You might contact Mary T Szela via mailing address: 10835 Road To The Cure, Suite 205, San Diego Ca 92121.